Naftifine

Dosage Forms & Strengths

topical cream

• 1%
• 2%

topical gel

• 1%
• 2%

Dermatophytoses

1% cream or gel: Apply BID to the affected areas plus a 0.5-inch margin of healthy surrounding skin for 4 weeks

2% cream or gel: Apply qDay to the affected areas plus a 0.5-inch margin of healthy surrounding skin for 2 weeks

Indications

• 1% cream: Indicated for treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organism Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum
• 1% gel: Indicated for treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organism Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton Tonsurans, and Epidermophyton floccosum
• 2% cream or gel: Indicated for treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organism Trichophyton rubrum

Dosage Forms & Strengths

topical cream

• 2%

topical gel

• 2%

Tinea Pedis

2% cream or gel: Indicated for treatment of interdigital tinea pedis caused by the organism Trichophyton rubrum

<12 years: Safety and efficacy not established

12-17 years

• Use 2% cream or gel
• Apply cream or gel qDay to the affected areas plus a 0.5-inch margin of healthy surrounding skin for 2 weeks

Tinea Cruris

Indicated for treatment of tinea cruris caused by the organism Trichophyton rubrum

<12 years: Safety and efficacy not established

12-17 years

• Use 2% cream
• Apply cream qDay to the affected areas plus a 0.5-inch margin of healthy surrounding skin for 2 weeks

Tinea Corporis

Indicated for treatment of tinea corporis caused by the organism Trichophyton rubrum

<2 years: Safety and efficacy not established

&ge2 years

• Use 1% topical cream
• Apply cream qDay to the affected areas plus a 0.5-inch margin of healthy surrounding skin for 2 weeks

Naftifine is a prescription medication used to treat fungal skin infections such as jock itch, ringworm, and athlete's foot. 

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

• Tell all of your health care providers that you take naftifine. This includes your doctors, nurses, pharmacists, and dentists.
• Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this medicine while you are pregnant.
• Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.

• If your symptoms or health problems do not get better or if they become worse, call your doctor.
• Do not share your drugs with others and do not take anyone else's drugs.
• Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.
• Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.
• Some drugs may have another patient information leaflet. Check with your pharmacist. If you have any questions about naftifine, please talk with your doctor, nurse, pharmacist, or other health care provider.
• If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened.

This information should not be used to decide whether or not to take this medicine or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about naftifine. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using naftifine.

Review Date: October 4, 2017

• Antifungal Agent, Topical

Tinea infections: Cream 1% and 2%, Gel 1%: Topical treatment of tinea cruris (jock itch), tinea corporis (ringworm), and tinea pedis (athlete's foot).

Tinea pedis: Gel 2%: Topical treatment of tinea pedis (athlete's foot).

Hypersensitivity to naftifine or any component of the formulation

There are no known significant interactions.

Concerns related to adverse effects:

• Irritation: Discontinue if sensitivity or irritation occurs and institute appropriate therapy.

Other warnings/precautions:

• Appropriate use: For topical use only; not intended for oral, ophthalmic, or vaginal use. Avoid use of occlusive dressings and contact with eyes, nose, mouth, or mucous membranes.